Judge Decertifies Class In Off-Label Neurontin Suit

Law360, New York (February 11, 2009, 12:00 AM EST) -- A Philadelphia judge has decertified a class in a putative action against Pfizer Inc. over off-label marketing of generic versions of its blockbuster epilepsy drug Neurontin, finding that the class members' circumstances are too varied to proceed as a class action.

Judge Mark I. Bernstein of the Court of Common Pleas for Philadelphia County ruled Monday that the lawsuit should not proceed as a class action because individual questions of fact outweigh questions common to all proposed class members.

Judge Bernstein granted preliminary certification to the...
To view the full article, register now.